Securities code: 600513 securities abbreviation: Jiangsu Lianhuan Pharmaceutical Co.Ltd(600513) Announcement No.: 2022-005
Jiangsu Lianhuan Pharmaceutical Co.Ltd(600513)
Announcement on notifying creditors of repurchase of some restricted shares
Special note: the board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1、 Reasons for notifying creditors
On January 21, 2022, the second extraordinary meeting of the eighth board of directors of Jiangsu Lianhuan Pharmaceutical Co.Ltd(600513) (hereinafter referred to as “the company”) deliberated and adopted the proposal on the unfulfilled lifting conditions of the first lifting period of the company’s restricted stock incentive plan in 2019 and the repurchase and cancellation of some restricted shares, According to the relevant provisions of the measures for the administration of equity incentive of listed companies and the company’s 2019 restricted stock incentive plan (Draft), it is agreed to repurchase and cancel the restricted shares of 14 incentive objects that do not meet the conditions for lifting the restrictions in the first lifting period.
A total of 844696 restricted shares were cancelled in this repurchase, accounting for 33.33% of the total granted under the equity incentive plan, and the repurchase price was 3.98 yuan / share.
After the cancellation of this repurchase, the total share capital of the company will be reduced from 287990370 shares to 287145674 shares, and the registered capital of the company will be reduced from 287990370 yuan to 287145674 yuan.
2、 Relevant information to be known to creditors
The repurchase and cancellation of some restricted shares by the company this time will reduce the registered capital. According to the company law of the people’s Republic of China and other relevant laws and regulations, the company hereby notifies the creditors. The creditors shall, within 30 days from the date of receiving the company’s notice or 45 days from the date of disclosure of this notice if they do not receive the notice, Have the right to require the company to pay off its debts or provide corresponding guarantees on the strength of valid creditor’s rights documents and relevant vouchers. If the creditor fails to exercise the above rights within the specified time limit, the cancellation of this repurchase will continue to be implemented in accordance with legal procedures. If the creditors of the company require the company to pay off its debts or provide corresponding guarantee, they shall submit a written request to the company in accordance with the relevant provisions of the company law of the people’s Republic of China and other laws and regulations, and attach relevant supporting documents.
Materials required for creditor’s rights declaration: the creditors of the company can declare their creditor’s rights to the company with the original and copies of contracts, agreements and other vouchers proving the existence of creditor’s rights and debt relationship. If the creditor is a legal person, it shall also carry the original and copy of the duplicate of the business license of the legal person and the identity certificate of the legal representative; In addition to the above documents, the original and copy of the power of attorney of the legal representative and the valid ID card of the agent shall also be carried. If the creditor is a natural person, it shall also carry the original and copy of the valid ID card; In addition to the above documents, the original and copy of the power of attorney and the agent’s valid ID card shall also be carried. The specific methods of creditor’s rights declaration are as follows:
1. Registration place of creditor’s rights declaration: No. 9, Jiankang 1st Road, Yangzhou biological health industrial park, Yangzhou City, Jiangsu Province
2. Contact: Securities Department of the company
3. Tel.: 0514-87813082
4. Fax No.: 0514-87815079
It is hereby announced.
Jiangsu Lianhuan Pharmaceutical Co.Ltd(600513) board of directors January 22, 2022
